Viromed Medical AG · ISIN: DE000A3MQR65 · Directors Dealings
Insider Transaction Snapshot

Viromed Medical AG

Directors Dealings: 20th November 2024
Reporting obligation triggered by: Perbandt, Uwe
Trading volume: 29.272,84 EUR
Type: Buy

The Insider Transaction was made by Perbandt, Uwe . The transaction toke place on 15th November 2024. The order was executed at the trading place Xetra. The aggregated volume was 29.272,84 EUR, based on an average price of 2,25 EUR. The nature of the Investment was Buy.

Short Selling Radar - Net Short Selling Positions

EQS-Newswire - Latest Company News, Ad-hoc News, Research

Directors Dealings

Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.

Reset filter
This might be interesting for you as well
New DD.i/o
27 March 2024
Eckert & Ziegler SE: A reportable insider transaction was published on 26th March 2024. The reporting obligation was triggered by a person related to Supervisory Board.

Transaction reporting date: 26th March 2024,

The Insider Transaction was made by Eckert, Dr. Andreas . The transaction toke place on 25th March 2024. . The aggregated volume was 247.699,20 EUR, based on an average price of 36,86 EUR. The nature of the Investment was Sell.

Eckert & Ziegler SE
27 March 2024
Eckert & Ziegler SE: A reportable insider transaction was published on 26th March 2024. The reporting obligation was triggered by a person related to Closely associated.

Transaction reporting date: 26th March 2024,

The Insider Transaction was made by Eckert Wagniskapital und Frühphasenfinanzierung GmbH . The transaction toke place on 25th March 2024. . The aggregated volume was 247.699,20 EUR, based on an average price of 36,86 EUR. The nature of the Investment was Buy.

Eckert & Ziegler SE
31 August 2023
Eckert & Ziegler Strahlen- und Medizintechnik AG: A reportable insider transaction was published on 30th August 2023. The reporting obligation was triggered by a person related to Supervisory Board.

Transaction reporting date: 30th August 2023,

The Insider Transaction was made by Eckert, Dr. Andreas . The transaction toke place on 28th August 2023. . The aggregated volume was 1.526.400,00 EUR, based on an average price of 31,80 EUR. The nature of the Investment was Sell.

Eckert & Ziegler Strahlen- und Medizintechnik AG
31 August 2023
Eckert & Ziegler Strahlen- und Medizintechnik AG: A reportable insider transaction was published on 30th August 2023. The reporting obligation was triggered by a person related to Closely associated.

Transaction reporting date: 30th August 2023,

The Insider Transaction was made by Eckert Wagniskapital und Frühphasenfinanzierung GmbH . The transaction toke place on 28th August 2023. . The aggregated volume was 1.526.400,00 EUR, based on an average price of 31,80 EUR. The nature of the Investment was Buy.

Eckert & Ziegler Strahlen- und Medizintechnik AG
31 August 2023
Eckert & Ziegler SE: A reportable insider transaction was published on 30th August 2023. The reporting obligation was triggered by a person related to Supervisory Board.

Transaction reporting date: 30th August 2023,

The Insider Transaction was made by Eckert, Dr. Andreas . The transaction toke place on 28th August 2023. . The aggregated volume was 1.526.400,00 EUR, based on an average price of 31,80 EUR. The nature of the Investment was Sell.

Eckert & Ziegler SE
31 August 2023
Eckert & Ziegler SE: A reportable insider transaction was published on 30th August 2023. The reporting obligation was triggered by a person related to Closely associated.

Transaction reporting date: 30th August 2023,

The Insider Transaction was made by Eckert Wagniskapital und Frühphasenfinanzierung GmbH . The transaction toke place on 28th August 2023. . The aggregated volume was 1.526.400,00 EUR, based on an average price of 31,80 EUR. The nature of the Investment was Buy.

Eckert & Ziegler SE
14 August 2023
Eckert & Ziegler Strahlen- und Medizintechnik AG: A reportable insider transaction was published on 11th August 2023. The reporting obligation was triggered by a person related to Supervisory Board.

Transaction reporting date: 11th August 2023,

The Insider Transaction was made by Perschmann, Frank . The transaction toke place on 11th August 2023. The order was executed at the trading place Tradegate. . The aggregated volume was 16.600,00 EUR, based on an average price of 33,20 EUR. The nature of the Investment was Buy.

Eckert & Ziegler Strahlen- und Medizintechnik AG
14 August 2023
Eckert & Ziegler SE: A reportable insider transaction was published on 11th August 2023. The reporting obligation was triggered by a person related to Supervisory Board.

Transaction reporting date: 11th August 2023,

The Insider Transaction was made by Perschmann, Frank . The transaction toke place on 11th August 2023. The order was executed at the trading place Tradegate. . The aggregated volume was 16.600,00 EUR, based on an average price of 33,20 EUR. The nature of the Investment was Buy.

Eckert & Ziegler SE
12 January 2023
Eckert & Ziegler Strahlen- und Medizintechnik AG: A reportable insider transaction was published on 11th January 2023. The reporting obligation was triggered by a person related to Management Board.

Transaction reporting date: 11th January 2023,

The Insider Transaction was made by Bouterfa, Dr. Hakim . The transaction toke place on 11th January 2023. . The aggregated volume was 124.800,00 EUR, based on an average price of 48,00 EUR. The nature of the Investment was Buy.

Eckert & Ziegler Strahlen- und Medizintechnik AG
22 December 2022
Eckert & Ziegler Strahlen- und Medizintechnik AG: A reportable insider transaction was published on 21st December 2022. The reporting obligation was triggered by a person related to Closely associated.

Transaction reporting date: 21st December 2022,

The Insider Transaction was made by Eckert Wagniskapital und Frühphasenfinanzierung GmbH . The transaction toke place on 19th December 2022. . The aggregated volume was 1.432.800,00 EUR, based on an average price of 47,76 EUR. The nature of the Investment was Buy.

Eckert & Ziegler Strahlen- und Medizintechnik AG
06 December 2022
Eckert & Ziegler Strahlen- und Medizintechnik AG: A reportable insider transaction was published on 6th December 2022. The reporting obligation was triggered by a person related to Supervisory Board.

Transaction reporting date: 6th December 2022,

The Insider Transaction was made by Maennig, Prof. Dr. Wolfgang . The transaction toke place on 6th December 2022. The order was executed at the trading place Xetra. . The aggregated volume was 72.745,31 EUR, based on an average price of 48,50 EUR. The nature of the Investment was Buy.

Eckert & Ziegler Strahlen- und Medizintechnik AG
14 June 2022
Eckert & Ziegler Strahlen- und Medizintechnik AG: A reportable insider transaction was published on 10th June 2022. The reporting obligation was triggered by a person related to Supervisory Board.

Transaction reporting date: 10th June 2022,

The Insider Transaction was made by Perschmann, Frank . The transaction toke place on 9th June 2022. The order was executed at the trading place Tradegate. . The aggregated volume was 19.547,00 EUR, based on an average price of 39,09 EUR. The nature of the Investment was Buy.

Eckert & Ziegler Strahlen- und Medizintechnik AG
More Eckert & Ziegler SE related information
Type Total Last Made by Go to
Equity Story 138 14th November 2024 EQS Group AG EQS
Corporate Research 0 - - Corporate Research
Short Seller (DE) 3 17th November 2022 JPMorgan Asset Management (UK) Ltd SSR (DE)
Short Seller (UK) 0 - - SSR (UK)
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

Important note:
The information presented here is usually updated once a day. Insofar as you include insider information/director dealings in your daily investment decisions and time-critical parameters play a role in the implementation of your trading strategy, you can obtain this information via a corresponding query at the BaFin or by monitoring the EQS-News intraday publications. 


Further information on the topic can be found on the following pages:

https://www.bafin.de/EN/Aufsicht/BoersenMaerkte/Transparenz/InformationspflichtenEmittenten/DirectorsDealings/directorsdealings_node.html https://www.bafin.de/DE/PublikationenDaten/Jahresbericht/Jahresbericht2016/Kapitel5/Kapitel5_2/Kapitel5_2_4/kapitel5_2_4_node.html https://www.bafin.de/DE/Aufsicht/BoersenMaerkte/Marktmissbrauch/Insiderueberwachung/insiderueberwachung_node.html https://www.bafin.de/DE/PublikationenDaten/Jahresbericht/Jahresbericht2017/Kapitel5/Kapitel5_2/Kapitel5_2_4/kapitel5_2_4_node.html https://www.bafin.de/DE/PublikationenDaten/Datenbanken/DirectorsDealings/directorsdealings_node.html